For the quarter ending 2026-03-31, PULM had -$67K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on mannkind transaction | - | - | 0 | 0 |
| Purchases of property and equipment | - | 0 | 0 | 0 |
| Fair value adjustment of warrants | - | 0 | 0 | -67 |
| Net cash used in investing activities | - | 0 | 0 | 0 |
| Depreciation and amortization | - | 0 | 0 | 0 |
| Amortization of operating lease right-of-use asset | - | 0 | 0 | 0 |
| Loss on disposals | - | 0 | - | - |
| Other long-term assets | - | 0 | 0 | -13 |
| Accounts receivable | - | 0 | 0 | 0 |
| Operating lease liability | - | 0 | 0 | 0 |
| Deferred revenue | - | 0 | 0 | 0 |
| Net loss | -1,172 | -928 | -877 | -3,357 |
| Stock-based compensation | 3 | 5 | 6 | 14 |
| Prepaid expenses and other current assets | 424 | -137 | -139 | -82 |
| Accounts payable | 379 | 203 | -315 | -425 |
| Accrued expenses and other current liabilities | 147 | -123 | 16 | 44 |
| Net cash used in operating activities | -1,067 | -706 | -1,031 | -3,696 |
| Proceeds from sale of series b convertible preferred stock | 1,000 | - | - | - |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | - | -706 | - | - |
| Cash provided by financing activities | 1,000 | - | - | - |
| Net decrease in cash, cash equivalents and restricted cash | -67 | -706 | -1,031 | -3,696 |
| Cash, cash equivalents and restricted cash beginning of period | 4,098 | 4,804 | 9,531 | - |
| Cash, cash equivalents and restricted cash end of period | 4,031 | 4,098 | 4,804 | - |
Pulmatrix, Inc. (PULM)
Pulmatrix, Inc. (PULM)